Antimicrobial stewardship program implementation in a medical intensive care unit at a tertiary care hospital in Saudi Arabia

Annals of Saudi Medicine

Volumn 33, Issue 6, 2013, Pages 547-554

  Amer, Marwa R ^a   Akhras, Nathem S ^a   Mahmood, Wafeeq A ^a   Al Jazairi, Abdulrazaq S ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CILASTATIN PLUS IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL STEWARDSHIP PROGRAM; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CONSULTATION; CONTROLLED STUDY; EVIDENCE BASED PRACTICE; FEEDBACK SYSTEM; FEMALE; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; INFORMED CONSENT; INSTITUTIONAL REVIEW; INTENSIVE CARE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MIDDLE AGED; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TERTIARY CARE CENTER;

ADULT; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; DRUG COSTS; DRUG RESISTANCE, BACTERIAL; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; SAUDI ARABIA; TERTIARY CARE CENTERS;

EID: 84893496437     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.5144/0256-4947.2013.547     Document Type: Article

References (36)

1. Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century a clinical super-challenge. N Engl J Med. 2009; 360(5):439-443.
2. Doron S, E. Davidson L. Antimicrobial stewardship. Mayo Clin Proc. 2011;86(11):1113-1123.
3. Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999; 115(2):462-474.
4. Lipsett, P. Antimicrobial Stewardship in the ICU. Contemporary Critical Care. 2008; 6(5): 1-12.
5. Owens RC Jr. Antimicrobial stewardship: application in the intensive care unit. Infect Dis Clin North Am. 2009;23(3):683-702.
6. Goff DA, Rybak MJ. Introduction to the special issue on antimicrobial stewardship. Pharmacotherapy. 2012; 32(8):663-664.
7. Ibrahim EH, Ward S, Sherman G, et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med. 2001; 29(6):1109-1115.
8. Carmeli Y, Troillet N, Karchmer AW, et al. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med. 1999; 159(10): 1127-1132.
9. Einarsson S, Kristjansson M, Kristinsson KG, et al. Pneumonia caused by penicillin-non-susceptible and penicillin-susceptible Pneumococci in adults: a case-control study. Scand J Infect Dis. 1998; 30(3):253-256.
10. Aldeyab MA, Kearney MP, Scott MG, et al. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother. 2012; 67(12): 2988-2996.
11. Al-Tawfiq JA, Abed MS. Clostridium difficile associated disease among patients in Dhahran, Saudi Arabia. Travel Med Infect Dis. 2010; 8(6): 373-376.
12. Palmer HR, Weston J, Gentry L, et al. Improving patient care through implementation of an antimicrobial stewardship program. Am J Health Syst Pharm. 2011;68(22):2170-2174.
13. Gauthier T, Unger N. Antimicrobial stewardship programs: A review for the formulary decisionmaker. Formulary. 2013; 48: 7-18
14. Pope SD, Dellit TH, Owens RC, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007; 44(2): 159-177.
15. ASHP initiative: Lead Stewardship Website. http://www.leadstewardship. org/index.php. (accessed 2013 May 10)
16. Centers for Disease Control and Prevention (CDC): Get Smart for Healthcare campaign. www.cdc.gov/getsmart/healthcare (accessed 2013 May 10)
17. Louie T. Antimicrobial stewardship: a review. Infect Dis Clin Pract. 2011;19(6):382-387.
18. Bartlett JG. A call to arms: the imperative for antimicrobial stewardship. Clin Infect Dis. 2011;53(1):4-7.
19. Cunha CB, Varughese CA, Mylonakis E. Antimicrobial stewardship programs (ASPs): The devil is in the details. Virulence. 2013; 4(2):147-149.
20. Charani E, Castro-Sanchez E, Sevdalis N, et al. Understanding the Determinants of Antimicrobial Prescribing Within Hospitals: The Role of "Prescribing Etiquette". Clin Infect Dis. 2013; 56 (12): 1-9.
21. Coll A, Kinnear M, Kinnear A. Design of antimicrobial stewardship care bundles on the high dependency unit. Int J Clin Pharm. 2012; 34(6):845-854.
22. Patel D, MacDougall C. How to Make Antimicrobial Stewardship Work: Practical Considerations for Hospitals of All Sizes. Hospital Pharmacy. 2010; 45(1): S10-S18.
23. Lawrence KL, Kollef MH. Antimicrobial stewardship in the intensive care unit: advances and obstacles. Am J Respir Crit Care Med. 2009; 179(6): 434-438.
24. Toth NR, Chambers RM, Davis SL. Implementation of a care bundle for antimicrobial stewardship. Am J Health Syst Pharm. 2010; 67(9): 746-749.
25. Njoku JC, Hermsen ED. Antimicrobial stewardship in the intensive care unit: a focus on potential pitfalls. J Pharm Pract. 2010; 23(1):50-60.
26. Abbo L, Lo K, Sinkowitz-Cochran R, et al. Antimicrobial Stewardship Programs in Florida's Acute Care Facilities. Infect Control Hosp Epidemiol. 2013;34(6):634-637 (abstract only)
27. Pate PG, Storey DF, Baum DL. Implementation of an antimicrobial stewardship program at a 60-bed long-term acute care hospital. Infect Control Hosp Epidemiol. 2012;33(44):405-408.
28. Cairns KA, Jenney AW, Abbott IJ, et al. Prescribing trends before and after implementation of an antimicrobial stewardship program. Med J Aust. 2013. 198 (5):262-266.
29. Cohen SH, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010; 31(5):431-455.
30. WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/ (accessed 2013 Mar 15)
31. Knaus WA, Draper EA, Wagner DP, et al. APACHE II : a severity of disease classification system. Crit Care Med. 1985; 13(10):818-829.
32. Al-Tawfiq JA, Stephens G, Memish ZA. Inappropriate antimicrobial use and potential solutions: a Middle Eastern perspective. Expert Rev Anti Infect Ther. 2010; 8(7):765-774.
33. Baadani AM, Thawadi SI, El-Khizzi NA, et al. Prevalence of colistin and tigecycline resistance in Acinetobacter baumannii clinical isolates from 2 hospitals in Riyadh Region over a 2-year period. Saudi Med J. 2013;34(3):248-253.
34. Borg MA, Cookson BD, Gür D, et al. Infection control and antibiotic stewardship practices reported by south-eastern Mediterranean hospitals collaborating in the ARMed project. J Hosp Infect. 2008;70(3):228-234.
35. Kaki R, Elligsen M, Walker S, et al. Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother. 2011; 66(6): 1223-1230.
36. Goff DA. iPhones, iPads, and medical applications for antimicrobial stewardship. Pharmacotherapy. 32(7): p. 657-61.